Formulating financials

If yesterday had been Wednesday s tomorrow, and if tomorrow is Sunday s yesterday, then what day is it today  

Compounding interest means that you split up the rate of interest into a designated number of subintervals (every three months, twice a year, daily, and so on), figure the interest earned during that subinterval, add the interest to the principal, and then figure the next interval s interest on the sum of the original principal plus the interest you ve added. As you may expect, you ll have more money in the end if you deposit it where you can earn compound interest rather than just a flat amount. The formula for compound interest 

---

Quality in the Chemical Industry. The chemical iadustry uses quahty as a strategic tool for financial success. Oae measure of quahty is the degree of product variatioa from lot to lot. Ia the chemical iadustry, it is oftea difficult to provide product speciftcatioas comprehensive eaough to easure product performance ia all apphcatioas (21). Therefore, the manufacture of product having a minimum of lot-to-lot variabihty allows the customer to use the product without modifying their formulation or process to accommodate such variation. 

Significant capital expenditure usually represents a substantial commitment of the resources of a business, both financially and in terms of man-hours. It is therefore incumbent upon management to ensure that proposals for such outlays receive proper and full consideration of all the relevant implications before implementation. Once policies as to levels of authorization and commitment are laid down, there should follow the formal appraisal of the financial effects of the proposal. These can be formulated only after detailed discussion with the appropriate departments as to all the physical, technical and environmental factors involved in making the final decision. There will also be brought into consideration, where pertinent, the marketing and sales effects. 

The first recorded reference to the use of expert systems in pharmaceutical product formulation was in the London Financial Times in the spring of 1989 [3], closely followed by an article in the autumn of the same year [4], Both referred to the work then being undertaken by personnel at ICI Pharmaceuticals, UK (now AstraZeneca) to develop an expert system for formulating pharmaceuticals ab initio. Since that time several companies and academic institutions have reported their experiences. 

Construct a drug treatment plan based on the disease severity and location. Identify potential contraindications or financial barriers to drug therapy. Inquire if the patient has an aversion to or inability to properly use certain drug formulations that you may wish to recommend, such as topical (rectal) products. 

Exposure-response data, however, are not likely to obviate the need for clinical data when formulation or manufacturing changes result in altered PKs, unless the relationships between measured responses and relevant clinical outcomes are well understood. The sponsors of studies need to make a financial evaluation of these studies as well often. 

At the same time, many formulators face increasingly difficult financial situations. Scotts leveraged buyout in 4986, as a prominent example, cost 2f f million (of which an investment-banking firm financed 490 million). This debt was blamed for the f f % fall in Scotts stock share price from June 4999 to June 2000. ... 

The goal of Approach 3 is to append an operational risk term to the mean-risk model formulation in Approach 2 to account for the significance of both financial risk (as considered by Approach 1) and operational risk in decision-making. 

A modern formulation of psychiatric disorders involves the integration of at least four key elements (1) genetic vulnerability to the expression of a disease (2) life event stressors that come that individual s way (divorce, financial problems, etc.) (3) the individual s personality, coping skills, and social support available from others ... 

It is not just machines which have surprises in store. During the due diligence for a financial investment we found that one of the portfolio companies had made an acquisition in which the formulation process was to be transferred from the US to a European facility. Whilst the transfer was quickly achieved unfortunately the... 

The costs of these latter development activities and the possible failure of processes, formulations or APIs at these stages have serious financial implications for any organization. Whilst the expenditure on developing new catalysts and new polymers can cost many hundreds of millions of dollars, in pharmaceuticals the total R D cost for a single drug is now approaching US 1 billion. 

According to the DOL, decisions in significant matters refers to the kind of decisions normally made by persons who formulate or participate in the formulation of policy, or who exercise authority within a wide range to commit their employer in substantial respects financially or otherwise. An exempt employee must exercise this kind of discretion and independent judgment customarily and regularly (daily). 

Figure 4.37 gives the combination of the simulation results obtained with the model and with an assembly of experimental data. We have to notice that the values of the factors for the relations that give the transition frequencies must respect the dimensional units from Table 4.7. These relations make it possible to formulate the optimisation of the filtration problem and then to establish the combination of factors allowing deep bed filtration at minimum financial cost. 

The integration board should consist of between two and four executive board members from the new company, the number depending on the scope of the integration. Its fundamental task is to control the general direction of the integration and to formulate guidelines for the individual project teams. It has to allocate the necessary human and financial resources, and to adopt measures that will bring about the declared objectives. 

The therapist may encoimter the clinical ramifications of bioavailability in regard to the issue of generic medications. Bioavailability is the benchmark measurement for determining bioequivalence between brand name and generic products. With many medications, generic formulations meet bioavailability standards and can provide economical alternatives to brand name products. This can be an important issue for psychiatric patients with limited financial resources, who often will simply... 

Financial incentives Process patent Use patent (e.g., new formulation) Market exclusivity (e.g., seven years for rare disease indication) Marketing rights granted for drug product if NDA submitted None... 

Manufacturers and producers of CAM products intended to treat or prevent disease and that will be marketed directly to consumers might not enjoy the same financial incentives, such as market exclusivity and patent protection as do drugs. For example, a drug that is approved by the FDA for prescription use is eligible for ary protection that remains under an existing patent. A pharmaceutical manufacturer may extend product exclusivity by obtaining a new patent for a revised formulation, such as a sustained release product that alters the bioavailability profile of the active component, or for a new indication. 

The financial support provided by the Army Research Office and Project Officer Dr. R. Seiders under contract DAAH04-95-K is gratefully acknowledged. The authors would also like to acknowledge Dr. J. Butt of Northwestern University for his assistance in the deactivation model and formulating the segmented bed experiments. 

It should be noted that the company might be wise to consider, when developing new formulations, that the minimum database acceptable to regulators might be insufficient for their own purposes. The decision to launch a new formulation has to be based not only on its technical success but also according to a financial analysis of the type referred to above for new indications. Crucial information on that question can usually only be obtained by studying the new formulation using one of the other authentic phase IV approaches described in this chapter. 

---